InfuSystem Holdings, Inc. (NYSE:INFU) Given Average Recommendation of “Buy” by Brokerages

Shares of InfuSystem Holdings, Inc. (NYSE:INFUGet Free Report) have been assigned an average rating of “Buy” from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $15.00.

Separately, Roth Mkm reiterated a “buy” rating and issued a $15.00 target price on shares of InfuSystem in a report on Tuesday.

Read Our Latest Research Report on InfuSystem

InfuSystem Price Performance

Shares of INFU stock traded up $1.02 on Tuesday, reaching $8.60. The company’s stock had a trading volume of 180,783 shares, compared to its average volume of 138,861. InfuSystem has a 1 year low of $4.61 and a 1 year high of $11.04. The company has a market capitalization of $174.89 million, a price-to-earnings ratio of 143.36 and a beta of 1.67. The stock’s fifty day simple moving average is $8.45 and its 200-day simple moving average is $9.33. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

Institutional Trading of InfuSystem

Several institutional investors have recently added to or reduced their stakes in the company. Hillsdale Investment Management Inc. purchased a new stake in InfuSystem during the 3rd quarter worth approximately $4,665,000. Arrowstreet Capital Limited Partnership increased its holdings in InfuSystem by 220.1% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 449,348 shares of the company’s stock worth $4,655,000 after acquiring an additional 308,974 shares in the last quarter. Ancora Advisors LLC purchased a new position in InfuSystem in the 3rd quarter valued at about $2,096,000. Teton Advisors LLC purchased a new position in InfuSystem in the 3rd quarter valued at $1,917,000. Finally, Truffle Hound Capital LLC acquired a new stake in InfuSystem in the 2nd quarter valued at about $1,123,000. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

(Get Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

Further Reading

Analyst Recommendations for InfuSystem (NYSE:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.